Ilmarinen相互养老金保险公司将Gilead Science股份增加近60%, 价值16.07M美元, Ilmarinen Mutual Pension Insurance Co boosts Gilead Sciences holdings by nearly 60%, worth $16.07M, as the company beats earnings estimates.

Ilmarinen相互养老金保险公司在Gilead Science Inc.的股份增加了59.6%,现在拥有174 000股,价值1 607万美元。 Ilmarinen Mutual Pension Insurance Co increased its holdings in Gilead Sciences, Inc. by 59.6%, now owning 174,000 shares worth $16.07 million. Gilead Science公司报告的收益为每股1.90美元,殴打估计数为0.23美元。 Gilead Sciences reported earnings of $1.90 per share, beating estimates by $0.23. 生物制药公司专门研发艾滋病毒/艾滋病、COVID-19和病毒性肝炎药品。 The biopharmaceutical company specializes in developing medicines for HIV/AIDS, COVID-19, and viral hepatitis. 机构投资者的地位各有不同,有些增加,另一些减少其持有量。 Institutional investors have mixed positions, with some increasing and others decreasing their holdings. Gilead Science的市场上限为133.54亿美元,“机动购买”评级为105.12美元的价格目标。 Gilead Sciences has a market cap of $133.54 billion and a "Moderate Buy" rating with a $105.12 price target.